The FAM53C/DYRK1A axis regulates the G1/S transition of the cell cycle

FierceBiotechIndivior warns of ‘significant impact’ on R&D team after opioid use disorder drug fails phase 2

FierceBiotechBMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecific

Endpoints NewsWhat we heard at a health tech conference in Boston

Promega BlogThe Filter You Didn’t Choose

FierceBiotechLabcorp raises full-year guidance, boosted by diagnostics, lab services

FierceBiotechLeo Pharma pays $50M for Replay and its preclinical skin disease gene therapy

Endpoints NewsCVS' healthcare delivery chief eyes potential in clinical AI

PharmaVoicePfizer deals extend patent life for a top-selling rare disease drug

FierceBiotechBeOne signs $2B deal for option on preclinical trispecific antibody from China’s Huahui

BioWorldMFDS clears Curocell’s anbal-cel as first homegrown CAR T therapy

Cytiva (Google News)Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing - Manufacturing Chemist

Endpoints NewsLack of specifics on obesity pill sales hover over Lilly’s first quarter